## Abstract Gene therapy for the treatment of heart failure is emerging as a multidisciplinary field demonstrating advances with respect to identifying key signaling pathways, modernized vector creation and delivery technologies. Although these discoveries offer significant progress, selecting opti
Polymers in gene therapy: antisense delivery systems
โ Scribed by Zvi H. Israel; Abraham J. Domb
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 266 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1042-7147
No coin nor oath required. For personal study only.
โฆ Synopsis
Antisense aligonucleotides can down-regulate or specifically turn off individual genes and have therefore received much attention in the era of gene therapy. While effective in vitro, delivery in vivo has been problematic. This review focusses on the progress of polymeric, non-viral methods of antisense delivery and also describes some of the exciting potential clinical applications of this technology.
๐ SIMILAR VOLUMES
Part 2\*: Gene Delivery Systems Used and Genes Transferred Delivery systems Gene delivery systems are based either on physicochemical methods or on biological methods (or a combination of the two). Gene Delivery systems used in humans to date are: Physico-chemical methods Biological methods Gene gun
## Abstract ## Background We have previously described the generation of reconstituting retroviral (ReCon) vectors designed for cancer gene therapy using cytotoxic gene products. The unique vector structure with a promoter physically separated from the transgene allows generation of stable virus p
Background Several nonviral vectors including linear polyethylenimine (L-PEI) confer a pronounced lung tropism to plasmid DNA when injected into the mouse tail vein in a nonionic solution. ## Methods and results We have optimized this route by injecting 50 mg DNA with excess L-PEI (PEI nitrogen/D